Monash IVF Group Ltd
ASX:MVF
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1.115
1.52
|
Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Monash IVF Group Ltd
Cash & Cash Equivalents
Monash IVF Group Ltd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Monash IVF Group Ltd
ASX:MVF
|
Cash & Cash Equivalents
AU$11.3m
|
CAGR 3-Years
9%
|
CAGR 5-Years
21%
|
CAGR 10-Years
3%
|
||
Pacific Smiles Group Ltd
ASX:PSQ
|
Cash & Cash Equivalents
AU$17.7m
|
CAGR 3-Years
17%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
||
Ramsay Health Care Ltd
ASX:RHC
|
Cash & Cash Equivalents
AU$662.3m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
15%
|
||
Regis Healthcare Ltd
ASX:REG
|
Cash & Cash Equivalents
AU$64.9m
|
CAGR 3-Years
156%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Estia Health Ltd
ASX:EHE
|
Cash & Cash Equivalents
AU$26.2m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
Monash IVF Group Ltd
Glance View
Monash IVF Group Ltd. engages in the field of fertility services. The company is headquartered in Richmond, Victoria and currently employs 669 full-time employees. The company went IPO on 2014-06-26. The firm also provides specialist women’s imaging services in Australia. The company operates through two segments, Monash IVF Group Australia and Monash IVF Group International. The Monash IVF Group Australia segment provides assisted reproductive services, ultrasound, and other related services. The Monash IVF Group International segment provides assisted reproductive services in Malaysia. The firm's business includes Fertility Solutions that provides fertility treatment and care; KL Fertility is a fertility specialist centre; Monash IVF is a fertility research and treatment center; Monash IVF KPJ Johor is a full-service hospital-based fertility centre; Monash Ultrasound for Women provides tertiary level prenatal diagnostic services; and Reproductive Medicine Albury is a provider of fertility treatments including In-vitro fertilization (IVF).
See Also
What is Monash IVF Group Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
11.3m
AUD
Based on the financial report for Jun 30, 2024, Monash IVF Group Ltd's Cash & Cash Equivalents amounts to 11.3m AUD.
What is Monash IVF Group Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
3%
Over the last year, the Cash & Cash Equivalents growth was 42%. The average annual Cash & Cash Equivalents growth rates for Monash IVF Group Ltd have been 9% over the past three years , 21% over the past five years , and 3% over the past ten years .